PLoS ONE (Jan 2021)

Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.

  • PLOS ONE Staff

DOI
https://doi.org/10.1371/journal.pone.0255429
Journal volume & issue
Vol. 16, no. 7
p. e0255429

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0252041.].